Share on StockTwits

Vitamin Shoppe (NYSE:VSI) will be posting its Q214 quarterly earnings results on Tuesday, August 5th. Analysts expect Vitamin Shoppe to post earnings of $0.63 per share and revenue of $306.09 million for the quarter.

Shares of Vitamin Shoppe (NYSE:VSI) traded up 1.14% during mid-day trading on Monday, hitting $42.63. The stock had a trading volume of 172,901 shares. Vitamin Shoppe has a 52 week low of $39.92 and a 52 week high of $55.20. The stock has a 50-day moving average of $43.5 and a 200-day moving average of $44.76. The company has a market cap of $1.291 billion and a P/E ratio of 19.42.

A number of research firms have recently commented on VSI. Analysts at Morgan Stanley initiated coverage on shares of Vitamin Shoppe in a research note on Tuesday, June 24th. They set an “overweight” rating and a $54.00 price target on the stock. On a related note, analysts at Bank of America upgraded shares of Vitamin Shoppe from an “underperform” rating to a “neutral” rating in a research note on Wednesday, June 4th. They now have a $47.00 price target on the stock. Finally, analysts at Barclays upgraded shares of Vitamin Shoppe from an “equal weight” rating to an “overweight” rating in a research note on Friday, May 9th. They now have a $51.00 price target on the stock, up previously from $49.00. Five analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $52.84.

Vitamin Shoppe, Inc is a specialty retailer and direct marketer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.